Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
about
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisCB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptorsAcute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats.Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells.Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissueEffect of Intermittent Hypoxia and Rimonabant on Glucose Metabolism in Rats: Involvement of Expression of GLUT4 in Skeletal Muscle.Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.Undaria pinnatifida and Fucoxanthin Ameliorate Lipogenesis and Markers of Both Inflammation and Cardiovascular Dysfunction in an Animal Model of Diet-Induced Obesity.Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats
P2860
Q26783956-822B3B0E-73C3-4796-8052-A22697BC5A6EQ28610813-313147A7-DCE0-419D-993D-E1D896B8718EQ34582334-DA2BE428-F0A3-41BE-AC5B-4B85048A91EEQ35228266-7DD99752-9357-41D2-A664-7AF969A003DFQ35597490-C13FCE10-2A6E-47F9-A504-428796B0AF4FQ36146799-F4A2B6C8-989A-42A3-BCE7-664040C94FF9Q36239149-C0726F47-E02C-4A0D-9B21-AF5409B19A09Q36556215-8CB56FE3-F393-45CC-B43C-DB1E47D825E0Q37209188-12B0D28E-EC78-4524-9967-0FBD3E2A5B21Q41207222-B5314E03-4624-427C-8AFE-4F7235173972Q46480886-98CBA909-DCA8-428C-9AEB-6A37BCB46D9AQ47445806-9F158BE0-A8E4-4E57-ABB2-763A0E45D8D8Q48018603-B75D134C-39C9-4074-A306-95D120C92D57Q58773071-1C7EE535-8DCB-4754-AC1D-22BABDD833FF
P2860
Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of adiponectin in the met ...... ice with diet-induced obesity.
@en
Role of adiponectin in the met ...... ice with diet-induced obesity.
@nl
type
label
Role of adiponectin in the met ...... ice with diet-induced obesity.
@en
Role of adiponectin in the met ...... ice with diet-induced obesity.
@nl
prefLabel
Role of adiponectin in the met ...... ice with diet-induced obesity.
@en
Role of adiponectin in the met ...... ice with diet-induced obesity.
@nl
P2093
P2860
P50
P921
P1476
Role of adiponectin in the met ...... ice with diet-induced obesity.
@en
P2093
George Kunos
Gergö Szanda
Grzegorz Godlewski
Joseph Tam
Liang Zhou
P2860
P304
P356
10.1152/AJPENDO.00489.2013
P577
2013-12-31T00:00:00Z